The earnings call reflected strong financial performance with substantial revenue growth, cost reduction, and international expansion. However, the company faces ongoing net losses and challenges in scaling international sales promptly. The sentiment is cautiously optimistic with positive growth indicators.
Company Guidance
During the Beyond Air Financial Results Call for the first fiscal quarter of 2026, the company reported a remarkable 157% year-over-year increase in revenue, reaching $1.8 million compared to the previous year's $700,000. This growth was driven by the continued market adoption of LungFit PH, reflecting a sequential 50% revenue increase from the previous quarter. The company also noted a significant reduction in operating expenses, which decreased to $7.5 million from $13 million the previous year, marking a 40% year-over-year reduction. Beyond Air reaffirmed its revenue guidance for fiscal year 2026, projecting a range of $12 million to $16 million. The company has expanded its international presence, now having access to over 30 countries through distribution partners, and has secured a national group purchasing agreement with Premier, providing access to nearly 3,000 hospitals. Additionally, Beyond Air reported a net loss of $7.7 million for the quarter, a reduction from the $12.2 million loss in the same period last year, and its net cash burn decreased by more than 60% year-over-year.
Significant Revenue Growth
Beyond Air reported a 157% increase in revenue for Q1 fiscal year 2026, reaching $1.8 million compared to $700,000 in the same period last year, and a 50% sequential increase from the previous quarter.
Cost Reduction Success
Operating expenses were reduced by 40% year-over-year to just above $7.5 million in the June quarter from $13 million for the same period last year.
International Expansion
First quarter of international revenues recorded with distribution partners covering more than 30 countries and over 2 billion lives.
Cash Burn Reduction
Net cash burn for the quarter was $4.7 million, more than 60% lower than the first quarter of the last fiscal year.
FDA Compliance
Beyond Air regained compliance with Nasdaq listing rules following a 1-for-20 reverse stock split.
Beyond Air (XAIR) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
XAIR Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 12, 2025
$3.16
$2.45
-22.47%
Jun 17, 2025
$5.70
$4.05
-28.95%
Feb 10, 2025
$8.75
$8.19
-6.40%
Nov 11, 2024
$10.20
$9.89
-3.04%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Beyond Air Inc (XAIR) report earnings?
Beyond Air Inc (XAIR) is schdueled to report earning on Nov 17, 2025, Before Open (Confirmed).
What is Beyond Air Inc (XAIR) earnings time?
Beyond Air Inc (XAIR) earnings time is at Nov 17, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.